ARCHIVES

Phase III Trial Retrospective Analysis Finds Talimogene Laherparepvec Reduced Tumors

This article is from The Cancer Letter archive.

Vol. 37 No. 3 | March 28, 2014

Download PDF Visit The Full Archive

Related Articles

DCBD Board Approves Recompetition Concepts, Including Cell Banks, Contrast Agents, Hepatoma Resources

November 14, 1980

Drasga and Einhorn Respond to Single Payer Proposal Rebuttal

February 14, 2014

Lenalidomide Safe As Single Therapy For Elderly Leukemia Patients, Study Finds

December 26, 2008

James Abbruzzese Moves to Duke Cancer Institute

September 27, 2013

FDA To Issue “Complete Response” Letters To Drug Sponsors.

July 11, 2008

Greenpeace Report Says Chemicals Causing Breast Cancers

October 22, 1993